New MS Drug

[T.O.fire]

Up here there was mention of an introduction of a new MS drug on a radio news show. Has anyone heard of such a new development?

[JonM]

oh wow, you really are "up there".  I'm in Florida.
lets hope there's something to this vaccine, but if I recall aren't vaccines primarily for preventing?  Can it help us who already have it??

JonM

[T.O.fire]

Sorry up here is Ontario Canada

And yes it is a vaccine that they are talking about, a Dr from Montreal.

[juless]

don't know if this has anything to do with what you're discussing, but I know that the Cleveland Clinic is running a clinical trial for ms patients right now...I actually heard about it when I made my appointment.  Maybe it's worthwhile??  

I also heard a news report on my local news the other day about a promising new ms vaccine and the positive response some patients have had with that?  

I really hope there's some light to be seen in the near future for those suffering!!

[6-paq]

Thanks for the info T.O.!!!  :)

Found this info.  These studies are now over, but has some links.

http://www.clinicaltrials.gov/ct/show/NCT00382629

http://www.clinicaltrials.gov/ct/show/NCT00103974

[JonM]

Sounds like a call for volunteers for a clinical trail.

Where is "Up here"?

JonM

[T.O.fire]

his research study is being done to evaluate the safety of BHT-3009 alone and when combined with atorvastatin (Lipitor) in patients with multiple sclerosis (MS).

Patients with MS are thought to have an immune response that attacks certain proteins in the brain, including myelin basic protein. (Myelin basic protein is a protein that makes up part of the outside layer of nerve cells.) BHT-3009 is an investigational immunotherapy product that is designed to alter the immune response to myelin basic protein and make the response less harmful. BHT-3009 contains the DNA (gene) for myelin basic protein.

Three different doses of BHT-3009 will be tested to determine if there are any differences in safety or effects on immunity. This is the first clinical research study of BHT-3009. Laboratory studies have shown that BHT-3009 and atorvastatin given together alters the immune response to myelin basic protein and makes the response less harmful.